The Asia Pacific Consortium of Veterinary Epidemiology (APCOVE) was established in 2020 to build veterinary epidemiology capacity across the Asia Pacific region. Led by the University of Sydney, APCOVE brings together over 50 animal health experts from all veterinary schools in Australia and New Zealand, and eight partner countries: Cambodia, Laos, Indonesia, Malaysia, Papua New Guinea, the Philippines, Timor-Leste, and Vietnam.

This project will provide targeted training of laboratory leaders in biorisk management and development of a community of biorisk practitioners in the region.

Malaysia imports 100% of its vaccines. Australia provided vaccines and technical assistance to support Malaysia’s response to the COVID-19 pandemic. At the end of the pandemic, this support pivoted to meet Malaysia’s ambitions at developing local capacity for vaccine development, including a national pilot-scale vaccine manufacturing facility at the Malaysia Genome and Vaccine Institute (MGVI).

Australia is supporting partner countries to build capacity for health systems to anticipate, prevent, detect and control priority disease threats through the Regional Engagement in Surveillance and response to Priority diseases, providing Opportunities for National health system strengthening and Development (RESPOND) partnership with Menzies School of Health Research. 

Australia is strengthening its commitment to the prevention, surveillance and response to infectious diseases across the Indo-Pacific through a strategic partnership with the Doherty Institute. Over the next four years, our partnership will focus on workforce development, policy support, and systems strengthening, and will specifically target laboratory strengthening, genomic surveillance, antimicrobial resistance (AMR), and data for decision making.

NCIRS is harnessing the collective skills of Australian Regional Immunisation Alliance (ARIA) members to support Ministries of Health and other key partners to strengthen immunisation programs across our region. ARIA is comprised of more than 65 experts and over 10 affiliated organisations, and works collaboratively with other agencies, including the WHO, UNICEF, and Gavi.

Australia's Department of Foreign Affairs and Trade is partnering with the Therapeutic Goods Administration (TGA) to co-deliver the Indo-Pacific Regulatory Strengthening Program (RSP). This program extends the previous TGA-led RSP and covers 22 countries across our region.

Australia is supporting the Global Alliance for TB Drug Development (TB Alliance) to advance TB treatments through innovative research and capacity building. TB Alliance is improving outcomes for all TB patients and communities through trialling and developing shorter, simplified and more affordable treatment regimes. To ensure faster uptake and access to new life-saving TB treatments, TB Alliance has created a Manila-based peer-to-peer knowledge hub for countries to learn from other national TB programs for implementation of new guidelines and to support clinical training.

IVCC develops innovative vector control tools to guard against malaria and dengue-carrying mosquitoes. With DFAT support, IVCC will expand a vector control toolbox tailored to Indo-Pacific contexts, better equipping countries to prevent and manage outbreaks and ultimately eliminate Vector Borne Diseases.
Activities include: